Monday - May 25, 2026
NIH: Oral Small-Molecule GLP-1 Drugs Penetrate Deep Into the Brain to Suppress Cravings
May 07, 2026
WASHINGTON, May 7 (TNSxrep) -- The U.S. Department of Health and Human Services' National Institutes of Health issued the following news release on May 6, 2026:

* * *

Oral small-molecule GLP-1 drugs penetrate deep into the brain to suppress cravings

NIH-funded research identifies new mechanism of action for next-generation weight-loss drugs

*

A National Institutes of Health (NIH)-funded study has found that an emerging class o . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Name:
What's your
Affiliation		 Government Newspaper / Media Business
Public Policy Individual / Student Educators
Email:
Phone:
Organization, if any:
State/Country you are in:
Additonal questions
or comments:

Click here for more information about our products

Click here for more information about our products